Loss of urate oxidase activity in hominoids and its evolutionary implications.
Level 5 - mechanism / opinion, no new human data
Evolutionary comparative genomic study analyzing primate sequence data without clinical trials or patient cohorts (assigned by design analogy).
PubMed 11961098 · doi:10.1093/oxfordjournals.molbev.a004123
What was done
The authors sequenced and compared the promoter, coding, and intronic regions of the urate oxidase (Uox) gene across multiple primate species to evaluate the evolutionary mechanisms and mutational events underlying the loss of uricase activity in hominoids.
What was found
Human and great ape Uox inactivation was confirmed to stem from a single CGA to TGA nonsense mutation in exon 2. In contrast, inactivation in the gibbon lineage arose independently via a different CGA nonsense mutation in exon 2, a single-base deletion in exon 3, or a single-base insertion in exon 5 (contradicting an earlier claim of a 13-bp deletion). Functional primate Uox genes showed high CGA codon usage prone to nonsense transitions alongside strong purifying selection at nonsynonymous sites. Substitutions in promoter cis-acting elements or CAAT boxes were also identified, suggesting a two-step deterioration process starting with lowered promoter transcription followed by coding region mutations.
Why it matters
This study clarifies the independent molecular events leading to uricase pseudo-genization across distinct hominoid lineages and provides an evolutionary framework for understanding elevated circulating uric acid levels and purine metabolism in humans.
Limits
The abstract does not state the total number of species or individual samples analyzed. Functional biochemical assays of transcriptional activity and direct links between uricase loss, oxidative stress protection, and lifespan extension remain unmeasured hypotheses.
Cited by
- supports Humans carry a mutation in the uricase gene that prevents the breakdown of uric acid.